HRT Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18M Buy
19,600
+13,400
+216% +$13.6M 0.05% 372
2025
Q4
$6.66M Buy
+6,200
New +$5.93M 0.02% 638
2025
Q3
Sell
-64,100
Closed -$50M 3310
2025
Q2
$50M Buy
64,100
+62,400
+3,671% +$48.5M 0.22% 55
2025
Q1
$1.4M Buy
+1,700
New +$1.41M 0.01% 969
2024
Q4
Sell
-8,200
Closed -$7.26M 2887
2024
Q3
$7.26M Buy
+8,200
New +$7.37M 0.04% 313
2024
Q2
Sell
-15,000
Closed -$11.7M 2702
2024
Q1
$11.7M Buy
+15,000
New +$10.7M 0.07% 133
2022
Q1
Sell
-1,400
Closed -$386K 3509
2021
Q4
$386K Buy
+1,400
New +$355K ﹤0.01% 2101

Other funds holding LLY

HRT Financial's LLY Position: Q1 2026 in Review

HRT Financial reduced its Eli Lilly (LLY) stake by 11% in Q1 2026, selling an estimated $6.93M and leaving 53,051 shares worth $48.8M. The position accounts for 0.12% of the portfolio, ranked #131.

HRT Financial first reported a position in LLY in Q4 2017 and has held it in 22 quarters since. The position peaked at $186M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • HRT Financial held 53,051 shares of Eli Lilly worth $48.8M as of Q1 2026.
  • HRT Financial sold 6,838 Eli Lilly shares in Q1 2026, an estimated $6.93M.
  • Eli Lilly made up 0.12% of HRT Financial's portfolio in Q1 2026, its #131 holding.
  • HRT Financial first reported a position in Eli Lilly in Q4 2017 and has held it in 22 quarters since.
  • HRT Financial's Eli Lilly position peaked at $186M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.